Psychotropic medications and traffic safety. Contributions to risk assessment and risk communication
PhD ceremony: Ms. S. Ravera, 12.45 uur, Academiegebouw, Broerstraat 5, Groningen
Dissertation: Psychotropic medications and traffic safety. Contributions to risk assessment and risk communication
Promotor(s): prof. J.J. de Gier, prof. L.T.W. de Jong-van den Berg
Faculty: Mathematics and Natural Sciences
Road traffic accidents constitute a major public health challenge and cause, every year, a large number of losses of life and injuries worldwide. In 2003, in its White Paper on transport policy, the European Commission fixed the target date of 2010 to halve the number of road deaths, and, in 2006, launched the European project Driving under the Influence of Drugs, Alcohol and Medicines (DRUID) with the purpose of obtaining scientific support to its transport policy to reach the 2010th road safety target.
The dissertation of Silvia Ravera is part of the DRUID project and aimed to assess the impact of psychoactive medications on traffic safety. The following research questions were developed and answered by her: 1) The dimension of the use of driving impairing medications in the general population; 2) The risks of experiencing a traffic accident while exposed to psychoactive medicines; 3) The development of criteria and methodology for establishing a European classification system for relevant therapeutic medication groups and driving. Briefly, Raveras results showed that the use of psychotropic medications remained quite constant over the last years, with the exception of antidepressants and, in particular, SSRIs (increased use over time). This latter group was associated with the highest risk of experiencing a traffic accident, even though experimental and epidemiological research did not always consistently report this relationship. Lastly, her work also established and defined standardized and harmonized criteria to categorise commonly prescribed medications, based on their influence on fitness to drive, in order to improve traffic safety and prevent motor-vehicle crashes.
Last modified: | 13 March 2020 01.01 a.m. |
More news
-
03 July 2025
Erik Heeres receives RUG Impact Innovator Excellence Award
During the RUG Ventures Innovation Day, Prof. Erik Heeres of the Faculty of Science and Engineering (RUG) was awarded the Impact Innovator Excellence Award.
-
02 July 2025
Relinde Weil reappointed as a member of the Supervisory Board UG
The Minister of Education has reappointed Relinde Weil for a second term as a member of the Supervisory Board of the University of Groningen.
-
02 July 2025
€ 30 million investment for UG spin-off Portal Biotech
Portal Biotech, a pioneer in nanopore-based protein identification and sequencing technology, has raised € 30 million in Series A funding. The funding will support commercial rollout and team growth.